| Financial Year |
March 31 2023 |
| Monetary Funds |
422,105,249.19 |
| Held-for-trading Financial Assets |
399,670,000.00 |
| Notes Receivable |
5,150,636.32 |
| Accounts Receivable |
1,092,406,760.44 |
| Advances to Suppliers |
313,233,496.99 |
| Other Receivables |
181,743,448.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
339,858,028.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
590,081,699.16 |
| Other Current Assets |
55,296,678.50 |
| Total Current Assets |
3,399,894,321.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
226,831,190.47 |
| Long-term Equity Investment |
100,000.00 |
| Investment Properties |
163,634,664.24 |
| Fixed Assetes |
77,478,644.44 |
| Under-construction Projects |
149,834,334.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,713,947.36 |
| R&D expenses |
590,943.39 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,321,590.88 |
| Deferred Income Tax Assets |
93,272,666.39 |
| Other Non-Current Assets |
15,638,748.19 |
| Sub-Total of Non-Current Assets |
920,476,668.39 |
| Total Assets |
4,320,370,989.44 |
| Short-Term Loans |
561,026,260.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
92,890,185.35 |
| Accounts Payable |
1,016,490,593.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
50,359,462.78 |
| Taxes Payable |
14,697,719.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
231,653,854.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
638,253,466.90 |
| Other Current Liabilities |
105,297,886.80 |
| Sub-Total of Current Liabilities |
2,863,301,173.48 |
| Long-term Loans |
199,100,600.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,444,448.69 |
| Deferred Income Tax Liabilities |
62,212,700.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
271,502,809.72 |
| Total Liabilities |
3,134,803,983.20 |
| Paid-In Capital(Or Share Stock) |
1,198,675,082.00 |
| Capital Surplus |
2,298,783,345.12 |
| Surplus Reserve |
41,576,362.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,396,426,523.76 |
| Minority Stockholder's Interest |
-16,546,218.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,202,113,224.97 |
| Owner's Equity（Stockholder's Equity） |
1,185,567,006.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,320,370,989.44 |
